 SAN MATEO, Calif., Dec. 23, 2020 PRNewswire -- Rakuten Medical, Inc. Rakuten Medical today announced that their Phase 1b2 clinical trial, an Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors... 